Abanza receives FDA 510(k) clearance of implantable ACL fixation system

Abanza Tecnomed has announced FDA 510(k) clearance of its WasherCap, an implantable soft-tissue graft fixation system for patients undergoing ACL reconstruction, according to a company press release.
WasherCap is designed to offer surgeons a strong fixation device regardless of patients' bone quality for ACL reconstruction, according to the release.
“The FDA clearance of WasherCap is exciting because it offers surgeons a highly reliable solution for soft-tissue graft fixation, especially valuable for young, adults and female patients, as well as revision procedures,” Juan Abascal,

Abanza Tecnomed has announced FDA 510(k) clearance of its WasherCap, an implantable soft-tissue graft fixation system for patients undergoing ACL reconstruction, according to a company press release.
WasherCap is designed to offer surgeons a strong fixation device regardless of patients’ bone quality for ACL reconstruction, according to the release.
“The FDA clearance of WasherCap is exciting because it offers surgeons a highly reliable solution for soft-tissue graft fixation, especially valuable for young, adults and female patients, as well as revision procedures,” Juan Abascal,